Amicus Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Amicus Therapeutics, Inc. (FOLD) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.210.290.290.480.160.450.50
Short-Term Investments0.040.040.140.240.320.000.00
Cash & Short-Term Investments0.250.290.290.480.480.450.50
Accounts Receivable0.100.090.070.050.050.030.02
Inventory0.120.060.020.030.020.010.01
Other Current Assets0.030.000.040.030.030.000.00
Total Current Assets0.500.480.420.600.580.520.55
Non-Current Assets
Property, Plant & Equipment (Net)0.050.060.060.060.070.080.01
Goodwill0.200.200.200.200.200.000.00
Intangible Assets0.020.020.020.020.000.000.00
Other Non-Current Assets0.010.020.020.020.020.030.01
Total Non-Current Assets0.280.290.300.310.310.330.24
Total Assets0.790.780.720.910.890.850.79
Current Liabilities
Accounts Payable0.010.160.110.120.020.120.06
Short-Term Debt0.010.000.000.000.000.000.00
Accrued Liabilities0.100.120.080.060.090.000.00
Other Current Liabilities0.110.040.020.020.010.030.00
Total Current Liabilities0.150.170.140.150.130.130.09
Non-Current Liabilities
Long-Term Debt0.440.440.440.430.390.200.32
Deferred Tax Liabilities0.000.000.000.000.000.000.00
Other Non-Current Liabilities0.010.010.020.010.020.030.00
Total Non-Current Liabilities0.440.450.460.450.470.240.36
Total Liabilities0.590.620.600.600.600.370.45
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-2.74-2.68-2.53-2.30-2.05-1.77-1.41
Accumulated Other Comprehensive Income0.010.01-0.010.000.020.000.00
Additional Paid-in Capital2.932.842.662.602.312.231.74
Shares Outstanding0.300.290.280.280.000.000.00
Total Stockholders' Equity0.190.160.120.310.290.480.34
Total Liabilities & Equity0.790.780.720.910.890.850.79